The abstract is read at the publisher; the summary is JClub's.
AminiCRoff, a dAsCas12f1-V8.1 KRAB–Dnmt3A/3L epigenome editor, suppresses H2B expression to 30% of baseline for up to 50 days after transient delivery.
- Why it matters: Long-term, programmable gene silencing is needed for research and potential epigenetic therapies, but compact CRISPRi/off systems that remain durable are limited.
- What they did: The authors optimized dAsCas12f1 variants fused to KRAB, selecting dCas12f1-V8.1-KRAB (AminiCRi) and then building dCas12f1-V8.1 with KRAB plus Dnmt3A/3L (AminiCRoff) to deposit H3K9 trimethylation and DNA methylation.
- The result: Transient AminiCRoff delivery yields stable repression of H2B to 30% baseline for as long as 50 days, and it is more durable than dSpCas9-based CRISPRoff.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.